2014 follow-up study was retracted in 2025, which means the foundational evidence base has significant integrity concerns that should be weighed carefully
Given its benefits for cardiovascular health, Semaglutide is also suitable for individuals with type 2 diabetes who are at high risk for cardiovascular events
GLP-1 RAs are currently being investigated for various new areas, such as cardiovascular diseases, non-alcoholic steatohepatitis (NASH), Alzheimers disease, and chronic kidney disease
If we can help someone shed 10, 20, or even 30 pounds now were not just helping them look different
Perfect for metabolic reset, PCOS protocols, HRT support, and performance-driven fat-loss programs
L.CambroneroF